Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1189 of 5804
-
New antibody BT02 takes on Hard-to-Treat blood cancers
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the safety, tolerability and preliminary effectiveness of a treatment for patients with relapsed or refractory hematologic malignancies, regardless of gender, aged between 18(inclusive) and 70 years . Participants will receive th…
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 17:49 UTC
-
New drug hopes to keep stage III lung cancer at bay after Chemo-Radiation
Disease control Not yet recruitingThis Phase II, open-label, single-arm study evaluates the efficacy and safety of one-year Ivonescimab consolidation therapy in patients with unresectable Stage III NSCLC who have not progressed after definitive chemoradiotherapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New cocktail of drugs and radiation targets Hard-to-Treat sarcoma
Disease control Not yet recruitingThis study intends to enroll patients with advanced soft tissue sarcoma, employing immunotherapy combined with eribulin, anlotinib, and radiotherapy as subsequent-line treatment to preliminarily explore its efficacy and safety. QL1706, a dual-targeting agent against PD-1 and CTLA…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Liver protein TREM-1 may predict steroid response in alcoholic hepatitis
Diagnosis Not yet recruitingBackground \& Rationale Severe alcohol-related hepatitis (SAH) is a serious condition with a 3-month mortality rate of \~30%. Diagnosis and prognosis are complex due to non-specific and insensitive clinical, biological, and histological indicators. Corticosteroids-the only valida…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 26, 2026 18:14 UTC
-
New trial aims to outsmart cancer by adjusting chemo doses in real time
Disease control Recruiting nowThis phase II trial evaluates the effect of capecitabine on tumor response using imaging and tumor markers to adjust dose (adaptive therapy) in patients with estrogen receptor (ER) positive, HER2 negative breast cancer that has spread from where it first started to other areas in…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Umbilical cord tissue may offer new option for bladder leakage surgery
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether a treated umbilical vein allograft is effective in treating stress urinary incontinence in females. The researchers will compare the treated umbilical vein allograft with a sling made of autologous tissue. The main question t…
Phase: PHASE3 • Sponsor: TBF Genie Tissulaire • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Handheld scanners and glucose monitors aim to catch diseases early
Diagnosis ENROLLING_BY_INVITATIONThis study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 partici…
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New combo procedure aims to seal aortic tears more completely
Disease control Not yet recruitingThis multicenter, prospective, observational study aims to evaluate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) combined with false lumen embolization using vascular plugs in patients with acute type B aortic dissection. Despite TEVAR being a standard t…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Earlier skull patch may boost brain healing
Disease control Not yet recruitingTo compare the neurological recovery and complication rate of autogenous cranioplasty(CP) within 6 weeks after decompressive craniectomy (DC) with that of autogenous cranioplasty within 3\~6 months after DC.
Phase: NA • Sponsor: The Affiliated Hospital Of Guizhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
Laser zaps brain tumor, then chemo moves in: new combo trial opens
Disease control Recruiting nowThis is a phase 1 study evaluating the safety and feasibility of laser interstitial thermal therapy (LITT) followed by lomustine (CCNU) for recurrent glioblastoma in adults. The primary aim is to evaluate the safety of the combination of LITT plus lomustine based on the assessmen…
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for seniors: targeted chemo may beat standard treatment for advanced colorectal cancer
Disease control Not yet recruitingWe plan to conduct a prospective, two-arm, open-label phase Ⅱ study to evaluate whether transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab significantly improves the efficacy and safety compared with systemic FOLFOX therapy plus/minus cetuxim…
Phase: PHASE2 • Sponsor: Junpeng Wang • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
One-Year combo pill strategy may boost CLL remission rates
Disease control Recruiting nowPeople who have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) are often treated with ibrutinib, acalabrutinib, or zanubrutinib. These are pills that are taken by mouth. This type of pill is called "Bruton Tyrosine Kinase Inhibitor" or BTKi. Another treatm…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could pressurized oxygen help veterans heal their brains?
Symptom relief Recruiting nowThe purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans. 1. Does Hyperbaric Oxygen Therapy improve cognitive functioning, p…
Phase: PHASE2 • Sponsor: Summit Hyperbarics and Wellness • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New study tests extra ablation targets to stop A-Fib recurrence
Disease control Not yet recruitingPulmonary Vein Isolation (PVI)-Only Group 1. Pulmonary vein isolation (PVI) will be performed, and the procedure will be terminated without the administration of isoproterenol following the standard waiting period. 2. In cases where spontaneous triggers are observed following PV…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Keto diet tested as new treatment for swollen limbs
Disease control Recruiting nowLymphedema is a debilitating disorder that severely impairs the quality of life of the patients and requires life-long attention. Treatment for lymphatic dysfunction remains largely symptomatic, without real cure. According to the International Society of Lymphology, lymphedema h…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
AI steps in to catch complications rheumatoid arthritis patients often miss
Diagnosis Recruiting nowGenerative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the diagnosis of various complications of rheumatoid arthritis (RA). In a retrospective study using RA patie…
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Robot therapist: can AI ease emotional pain after cancer surgery?
Symptom relief Recruiting nowTo develop the E-MOTE robot and evaluate its effectiveness in addressing psychological distress, physical symptom, stress index, and quality of life, as well as to explore its clinical applicability.
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Could taking epilepsy meds three times a day stop more seizures?
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate the efficacy and tolerability of Levetiracetam administered three times daily in patients with epilepsy. The primary objective is to investigate whether orally administered Levetiracetam three times daily dosing is superior in sei…
Phase: PHASE3 • Sponsor: Waad Alkathiri • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could light and magnets finally heal stubborn leg wounds?
Disease control Recruiting nowChronic leg and foot ulcers are defined as wounds that fail to heal in a timely manner, typically persisting for over 4 to 8 weeks without substantial healing despite standard care. These ulcers often result from macro- and microvascular disorders, the most common being chronic v…
Phase: PHASE4 • Sponsor: Sebastian Probst • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Fish oil cocktail takes on stubborn ear fluid in adults
Disease control CompletedBrief Summary - OMENUTS Trial Otitis media with effusion (OME) is a condition in which fluid accumulates in the middle ear, causing conductive hearing loss, ear fullness, tinnitus, and Eustachian tube dysfunction. Although OME is well-recognized in children, it also affects adult…
Phase: PHASE4 • Sponsor: Isola Tiberina - Gemelli Isola Hospital, Rome, Italy • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC